Bringing infectious disease studies to patients

Curebase infectious disease trials successfully enroll patients utilizing a new kind of model that meets patients where they are through community healthcare and virtual settings

Download

Discover how Curebase strategically designs infectious disease studies such as COVID, Streptococcus, Lyme Disease, Chlamydia, and more with an advanced execution approach to fast-track studies and optimize targeted recruitment.
‍
In this white paper you’ll discover:

How Curebase allowed research to prevail through the height of the COVID-19 pandemic.
Curebase’s ability to optimize enrollment, expedite prescreening, screening, and eConsent, and streamline information flow.
How Curebase’s unique traditional and non-traditional testing site-activation strategies bring studies to where participants are.
How customizable dashboards enable sponsors to get study data in real-time and see participant progress at any stage.